All Stories

  1. Fragile X Syndrome: Recent Research Updates toward Capturing Treatments’ Improvement in Clinical Trials

    Article • Brain Sciences, September 2022, MDPI AG

    Dragana Protic

  2. New Targeted Treatments for Fragile X Syndrome

    Article • Current Pediatric Reviews, December 2019, Bentham Science Publishers

    Maria Salcedo-Arellano, Dragana Protic

  3. Fragile X-Associated Neuropsychiatric Disorders (FXAND)

    Article • Frontiers in Psychiatry, November 2018, Frontiers

    Dragana Protic

  4. Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals

    Article • Frontiers in Neuroscience, September 2018, Frontiers

    Dragana Protic

  5. Knowledge about blood-borne pathogens and the prevalence of needle stick injuries among medical students in Serbia

    Article • Slovenian Journal of Public Health, January 2017, De Gruyter

    Dragana Protic

  6. Patient autonomy and informed consent in critically lll

    Article • Hospital Pharmacology - International Multidisciplinary Journal, January 2017, Centre for Evaluation in Education and Science (CEON/CEES)

    Dragana Protic

  7. Nosocomial coagulase-negative staphylococci in Belgrade: between Scylla and Charybdis

    Article • The Journal of Infection in Developing Countries, September 2016, Journal of Infection in Developing Countries

    Dragana Protic

  8. adverse drug reactions to β-blockers

    Article • Patient Preference and Adherence, August 2016, Dove Medical Press

    Prof. Natasa ND Djordjevic, Mrs Snežana Mugoša, Professor Zoran Todorović, Dragana Protic

  9. Nosocomial Infections Caused byAcinetobacter baumannii: Are We Losing the Battle?

    Article • Surgical Infections, April 2016, Mary Ann Liebert Inc

    Dragana Protic

  10. Profile of rheumatology patients willing to report adverse drug reactions: bias from selective reporting

    Article • Patient Preference and Adherence, February 2016, Dove Medical Press

    Professor Zoran Todorović, Snežana Baltić, Nada Stupar, Marija Zdravkovic, Dragana Protic

  11. Drugs development and fragile X syndrome translational success story

    Article • Medicinski podmladak, January 2016, Centre for Evaluation in Education and Science (CEON/CEES)

    Dragana Protic

  12. Clopidogrel-statin interaction: A missing links

    Article • Hospital Pharmacology - International Multidisciplinary Journal, January 2016, Centre for Evaluation in Education and Science (CEON/CEES)

    Dragana Protic

  13. FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia

    Article • Vojnosanitetski pregled, January 2016, National Library of Serbia

    Dragana Protic

  14. Adverse drug reactions in hospitalized cardiac patients: Characteristics and risk factors

    Article • Vojnosanitetski pregled, January 2015, National Library of Serbia

    Dragana Protic

  15. The Different Effects of Resveratrol and Naringenin on Isolated Human Umbilical Vein: The Role of ATP-Sensitive K+ Channels

    Article • Phytotherapy Research, March 2014, Wiley

    Professor Ljiljana C Gojkovic-Bukarica, Dragana Protic

  16. Cardiovascular effects of resveratrol

    Article • Vojnosanitetski pregled, January 2013, National Library of Serbia

    Dragana Protic

  17. Bioethical issues in the development of biopharmaceuticals

    Article • Filozofija i drustvo, January 2012, National Library of Serbia

    Dragana Protic